Oct 9, 2026 - 7 AI models call event-driven stocks in the morning session. 3 models beat SPY over the window

Asked Oct 9, 10:12 AM EDT (morning session). GPT-6, Muse Spark 1.1, Gemini 1.5 Pro, Perplexity, Grok 4.5, Claude Sonnet 5.5 and DeepSeek answered the same standard prompt independently. Window: from Oct 9, 10:12 AM EDT to Oct 12, 10:12 AM EDT, the same time one session later. Benchmark: SPY.

Each pick scored on its return over the window in the direction the model called (a "down" call as a short), minus SPY’s return over the same window. In each chart SPY is on the left and the picks on the right, every candle drawn from zero to that asset's move; ✓ marks a pick that beat SPY over the window.

Model	Correct	Hit rate	Return	SPY	Alpha vs SPY
GPT-6	1/5	20.00%	0.38%	0.22%	0.16%
Muse Spark 1.1	2/5	40.00%	-0.18%	0.22%	-0.40%
Gemini 1.5 Pro	2/5	40.00%	0.39%	0.22%	0.17%
Perplexity	0/5	0.00%	-2.28%	0.22%	-2.50%
Grok 4.5	3/5	60.00%	0.69%	0.22%	0.47%
Claude Sonnet 5.5	0/5	0.00%	-2.30%	0.22%	-2.52%
DeepSeek	1/5	20.00%	-0.66%	0.22%	-0.88%

GPT-6

View full picks and reasoning

US equities are responding to unusually concentrated company-specific catalysts on October 9, 2026. The strongest observed developments are Humana's improvement in Medicare Advantage Star Ratings, SpaceX's announced spectrum acquisition and its implications for wireless carriers and tower operators, and Delta Air Lines' disappointing third-quarter results and reduced guidance. The portfolio favors selective continuation of fundamental repricing, a partial recovery in oversold wireless carriers, and further weakness in Delta. Major risks include emotional overreaction, profit-taking after overnight gaps, changing interest rates, geopolitical developments, and the weekend between the two measurement points. All forecasts concern incremental returns from the already-running window, not the overnight or opening moves already realized. The reference prices below are intraday observations from October 9, not necessarily simultaneous with the prediction timestamp. Market capitalizations are reported from the displayed market-data source. Exact trailing 20-session dollar-volume averages were not directly available; the reported liquidity figures are explicitly identified as proxies calculated from published 20-day average share volume multiplied by the latest observed reference price. These proxies are not independently verified historical dollar-volume averages. Every candidate exceeds the $20 million threshold by a substantial margin under this proxy, but strict verification of the exact liquidity metric remains incomplete. Event timestamps using 00:00:00Z are date-only evidence markers, not assertions about an actual announcement or transaction time. No future earnings, transaction approval, or operating outcome is treated as an observed fact.

1. HUM — confidence 68%. Bullish continuation following an observed, economically meaningful improvement in Medicare Advantage Star Ratings. Humana announced that 95% of its Medicare Advantage members are enrolled in plans rated at least four stars for 2027. This substantially improves expectations for future quality-related bonus payments and profitability. Analysts responded with significant upgrades and price-target increases. The stock had already advanced approximately 12.87% to $436.96 by the observed 10:03 a.m. EDT quote, so that gain is excluded from this forecast. The remaining opportunity is additional institutional repricing as investors incorporate the improved ratings into earnings estimates. The anticipated incremental gain is comparatively modest because much of the catalyst has already been priced in. Risks include profit-taking after the sharp opening rally, valuation concerns, uncertainty regarding ultimate realized bonus payments, and a reversal if investors conclude that the ratings improvement was already anticipated. Reference price is an observed October 9 regular-session intraday quote. The reported dollar-volume figure is a current-price proxy, not a measured 20-session average of daily dollar turnover.
   Return: -0.40%; alpha: -0.62%.
2. CCI — confidence 60%. Bullish continuation driven by renewed expectations for terrestrial communications infrastructure demand. SpaceX's announced acquisition of low-band spectrum supports its ambitions to expand Starlink Mobile coverage. Investors initially interpreted the development as favorable for cell-tower infrastructure owners, including Crown Castle. The observed price of $76.39 at 10:11 a.m. EDT already represented a 10.89% advance, which is excluded from the incremental forecast. Additional upside could follow further institutional reassessment of the amount of terrestrial infrastructure needed to support expanded mobile coverage. Crown Castle's officially announced October 21 earnings release provides a secondary, later catalyst for investor positioning, although the report occurs outside this window. The key uncertainty is whether Starlink will actually require enough conventional tower infrastructure to materially benefit Crown Castle. Emotional continuation risk is particularly elevated after the double-digit rally, and profit-taking or a reassessment of the satellite-versus-tower economics could produce a sharp reversal. Reference price is an observed October 9 regular-session intraday quote. The dollar-volume figure is a current-price proxy rather than an independently verified 20-session dollar-turnover average.
   Return: 3.75%; alpha: 3.53%.
3. TMUS — confidence 63%. Contrarian bullish forecast after an exceptionally sharp selloff caused by concerns about future satellite-based wireless competition. SpaceX's spectrum acquisition raises a genuine long-term strategic threat to conventional mobile operators, but the timing and economic impact of its proposed network remain uncertain. T-Mobile shares were already down approximately 9.17% to $155.60 at the observed 9:56 a.m. EDT quote. That decline has already happened and is not part of the predicted return. The forecast anticipates a partial recovery as investors distinguish a strategic announcement from an immediately operational national mobile network. T-Mobile's established subscriber base, wireless network, and existing service infrastructure offer potential resilience against rapid competitive displacement. Risk factors include further analyst downgrades, negative headlines about SpaceX's ambitions, accelerated industry repricing, and continued emotionally driven selling. This is explicitly a reversal forecast from the observed intraday level, not a prediction that the original negative reaction will disappear. Reference price is an October 9 intraday quote. The reported liquidity measure uses the latest price multiplied by published 20-day average share volume.
   Return: -0.39%; alpha: -0.61%.
4. T — confidence 61%. Bullish short-term reversal following a large risk-driven decline in telecommunications shares. AT&T fell approximately 6.56% to an observed $22.98 at 9:58 a.m. EDT as investors reassessed potential long-term competition from SpaceX's Starlink Mobile initiative. The forecast expects part of the selling pressure to reverse over the remaining measurement window because the announced spectrum acquisition does not immediately establish a nationwide retail wireless business. The FCC approval process, infrastructure deployment, technology maturity, and customer acquisition requirements introduce substantial uncertainty about the timeline and ultimate competitive consequences. AT&T's established cash-generating operations may provide some valuation support. The October 9 ex-dividend date is an additional observed corporate-calendar consideration; the experiment excludes dividends, and price comparisons should use the specified consistent split-adjusted share basis without treating a mechanical ex-dividend adjustment as positive performance. Risks include additional downgrades, continued liquidation across telecom holdings, and adverse competitive interpretations. The reference price is an October 9 intraday quote and the liquidity amount is a calculated current-price proxy, not a directly sourced trailing dollar-volume average.
   Return: -0.96%; alpha: -1.19%.
5. DAL — confidence 65%. Bearish continuation after disappointing reported earnings and a material reduction in full-year profit guidance. Delta reported third-quarter adjusted earnings of $1.72 per share and revenue of $17.59 billion, below market expectations. Higher fuel costs contributed to the weakness, and management reduced its full-year adjusted EPS outlook from $6.50-$7.50 to $5.10-$5.60. The reduction in expected annual profitability is more significant than an isolated quarterly miss because it suggests weaker earnings power in the present fuel-cost environment. The stock was already down approximately 2.43% to $80.15 at the observed 9:55 a.m. EDT quote, and that decline is excluded from this forecast. Further downside could arise from analyst earnings revisions, reduced institutional positioning, and continued concern about energy prices and Middle East disruptions. A competing bullish scenario is that lower oil prices and resilient passenger demand lead investors to regard the earnings disappointment as temporary. The forecast favors a further moderate decline rather than extrapolating the initial earnings reaction. Reference price is an October 9 regular-session intraday quote. The reported dollar liquidity is a proxy calculated from price and average share volume.
   Return: 0.09%; alpha: -0.31%.

Full prediction and audit record

Muse Spark 1.1

View full picks and reasoning

Market is in earnings kickoff with Delta opening airline season and Levi closing retail Q3, while a sudden competitive shock from 【entity-SpaceX¦canonical_name=SpaceX】 buying nationwide 800 MHz low-band spectrum for Starlink Mobile is repricing telecom. Premarket shows telecom down 5-7% and airlines soft after DAL miss. Expect momentum continuation through Oct 9-12 window as guidance cuts and spectrum threat are digested.

1. DAL — confidence 78%. Delta Air Lines reported Q3 2026 on Oct 9 before open, EPS $1.72 vs $1.77 consensus and revenue $17.59B vs $17.65B, plus cut full-year outlook citing jet fuel pressure from Middle East war. Price was $80.55 intraday Oct 9 down 1.94% from $82.14 prior close. Market reaction is observed and continuing. Downside risk is earnings miss continuation into next session. Meets floors: price ~$80, market cap ~$56B, avg dollar volume >$300M.
   Return: 0.09%; alpha: -0.31%.
2. TMUS — confidence 75%. T-Mobile US is leading telecom selloff after 【entity-SpaceX¦canonical_name=SpaceX】 announced definitive agreement to acquire up to 14 MHz of paired 800 MHz low-band nationwide spectrum from Grain Management for Starlink Mobile, enabling direct competition as major US carrier. TMUS fell 6.3% premarket Oct 9 to $158.93. Event occurred Oct 8 after close, officially announced, not uncertain expectation. Threat to pricing power and subscriber base drives further downside through window.
   Return: -0.39%; alpha: 0.17%.
3. T — confidence 72%. 【entity-AT&T¦canonical_name=AT&T】 fell 5.7% premarket Oct 9 to $23.10 after 【entity-SpaceX¦canonical_name=SpaceX】 spectrum deal. Same catalyst as TMUS/VZ, observed Oct 8 announcement. 【entity-AT&T¦canonical_name=AT&T】 most exposed to low-band competition due to legacy spectrum dependence. Price floor met, market cap $170B, volume >$500M daily. Continuation risk high as analysts cut telecom multiples.
   Return: -0.96%; alpha: 0.74%.
4. VZ — confidence 70%. 【entity-Verizon¦canonical_name=Verizon】 fell 5.1% premarket to $43.71 overnight and $46.35 prior close Oct 8. Same 【entity-SpaceX¦canonical_name=SpaceX】 spectrum catalyst. Observed fact, not scheduled future event. Downside expected as market prices new entrant with nationwide low-band. Meets price $46, cap $192B, volume >$400M.
   Return: -0.21%; alpha: -0.01%.
5. LEVI — confidence 65%. Levi Strauss reported Q3 FY2026 Oct 7 after close, EPS $0.48 vs $0.36 est beat 33%, revenue $1.61B in line. However stock fell 7.6% after hours Oct 8 to $18.53 because beat driven by tariff refunds, gross margin +450 bps one-time, and FY26 guidance 1.54-1.56 EPS vs consensus 1.54 and revenue $6.7B vs $6.8B est slight miss. Observed earnings, market still digesting quality of beat. Expect continued downside through window.
   Return: 2.38%; alpha: -2.60%.

Full prediction and audit record

Gemini 1.5 Pro

View full picks and reasoning

US equity markets are mixed to slightly higher, with the broader indices holding near record levels despite notable underlying rotation. Weakness in AI monetization prospects—catalyzed by lower-than-expected OpenAI revenue signals—is driving a sharp pullback in semiconductor and AI infrastructure stocks. Meanwhile, specific stock catalysts, such as Humana's Medicare Advantage star rating upgrade and Delta's weak forward guidance, are dominating individual price action. Overall, index-level calm is masking elevated single-stock volatility driven by real-time fundamental developments.

1. DAL — confidence 85%. Delta Air Lines missed Q3 earnings estimates and slashed its 2026 profit outlook, citing persistent high fuel prices. Shares are trading down nearly 5% in the early session. We expect negative sentiment to persist through the end of the window as analysts begin adjusting their models downward and investors digest the weaker forward guidance.
   Return: 0.09%; alpha: -0.31%.
2. AAPL — confidence 80%. Apple shares are facing pressure following a Nikkei Asia report that the company instructed suppliers to cut component orders for the iPhone 18 Pro and Pro Max by 15% to 20% for October. This signals weaker-than-anticipated demand for its flagship devices. The resulting negative momentum is likely to weigh on the stock over the next trading session.
   Return: 2.84%; alpha: -3.06%.
3. HUM — confidence 75%. Humana surged after the Centers for Medicare and Medicaid Services (CMS) restored its largest Medicare Advantage contract to a 4-star rating for 2027. This reinstates Humana's eligibility for crucial quality bonus payments, a major fundamental positive. The sudden removal of this structural overhang has triggered a strong rally, and we anticipate continuation buying throughout the window.
   Return: -0.40%; alpha: -0.62%.
4. CEG — confidence 70%. Constellation Energy is extending its recent gains after Google announced a significant long-term power purchase agreement with the utility. This deal underscores the surging demand for clean, reliable energy to power AI data centers. The confirmed contract provides revenue visibility and validates CEG's strategic positioning, driving continued investor accumulation.
   Return: 1.46%; alpha: 1.24%.
5. AMD — confidence 75%. Advanced Micro Devices is trading lower following a report indicating that OpenAI's annualized revenues were sharply below prior estimates. As AMD is a key hardware provider for AI workloads, doubts regarding the immediate monetization of downstream AI services are causing investors to trim semiconductor exposure. We expect this risk-off sentiment in AI names to persist in the near term.
   Return: -3.82%; alpha: 3.60%.

Full prediction and audit record

Perplexity

View full picks and reasoning

US equities are stabilizing after a tech-led selloff, but single-stock catalysts remain dominant: Medicare star ratings, an FDA approval, airline earnings guidance, iPhone supply-chain reports, and AI optical-demand commentary can drive outsized one-day moves. I favor names with fresh, verifiable catalysts and sufficient liquidity, while acknowledging that large premarket gaps can mean emotional continuation or reversal during the session.

1. HUM — confidence 72%. Humana is the strongest observed catalyst: CMS's 2027 Medicare Advantage Star Ratings were released and Humana said 95% of members would be in plans rated four stars or higher in 2027, versus 20% in 2026. This has occurred, and the stock surged roughly 15% premarket; quality ratings materially affect future Medicare bonus revenue. I expect continued upward follow-through as investors reprice 2027 revenue quality, though a 15% gap creates reversal risk if traders take profits or the broader managed-care complex fades. Reference price is a delayed premarket quote.
   Return: -0.40%; alpha: -0.62%.
2. TEVA — confidence 63%. Teva announced FDA approval of WELTRUZA (olanzapine) extended-release injectable suspension, its once-monthly subcutaneous long-acting injectable for schizophrenia in adults. The approval has occurred and TEVA rose about 4.2% premarket. A new branded LAI adds a potential growth and margin lever for a company still working through debt and generic-drug pressures, supporting continuation. Risks include profit-taking after the gap, launch-timing and reimbursement uncertainty, and the fact that the approval is already public rather than a future surprise. Reference price is a delayed premarket quote.
   Return: -1.22%; alpha: -1.44%.
3. DAL — confidence 61%. Delta reported Q3 adjusted EPS of $1.72 and revenue of $17.59 billion, below LSEG consensus of $1.75 and $17.67 billion, and cut its full-year earnings outlook while citing higher fuel costs. The earnings event has occurred. The stock fell about 4% premarket, and I expect additional downside as investors digest lower guidance, fuel-cost pressure, and the earnings call scheduled for 10:00 AM ET. The main risk is a rebound if management's commentary is more constructive than the headline guidance cut. Reference price reflects the latest available intraday/premarket data.
   Return: 0.09%; alpha: -0.31%.
4. AAPL — confidence 58%. Apple fell about 2.5% premarket after Nikkei Asia reported that Apple told some suppliers to cut component orders for iPhone 18 Pro and iPhone 18 Pro Max, with reports citing at least a 15% October order reduction. This is a news-driven, not company-confirmed, catalyst, so it is an uncertain expectation about demand rather than an officially scheduled event. Continued selling is plausible as investors mark down near-term iPhone unit assumptions, but Morgan Stanley reportedly did not detect major supply-chain changes and maintained estimates, creating a meaningful rebound risk. Reference price is a delayed premarket quote.
   Return: 2.84%; alpha: -3.06%.
5. LITE — confidence 55%. Lumentum rose 3.8% to 6% premarket after CEO Michael Hurlston said its optical components are effectively sold out through early 2029 and that the company may struggle to meet as much as 70% of demand for some products next year. This is an observed management commentary catalyst, not a scheduled earnings release. The commentary supports an upward repricing of optical/AI infrastructure demand, but the stock is extremely expensive and volatile, and a large premarket move can reverse if the broader AI trade weakens. Reference price is the latest available premarket indication; an exact live regular-session price was not available in the evidence gathered.
   Return: -6.85%; alpha: -7.07%.

Full prediction and audit record

Grok 4.5

View full picks and reasoning

Markets are digesting Delta's Q3 miss and guidance cut alongside SpaceX's spectrum deal that pressured major telecom carriers after hours Thursday into Friday. Bank earnings kick off Tuesday, so Monday's session will reflect positioning and anticipation ahead of JPM, GS, UNH and peers. Breadth is mixed with oil easing and AI jitters fading, favoring event-driven moves over broad beta.

1. DAL — confidence 72%. Delta reported Q3 adjusted EPS of $1.72 versus ~$1.75-1.80 consensus and cut full-year 2026 EPS guidance to $5.10-$5.60 from $6.50-$7.50, citing elevated fuel costs. Shares already fell 2-3% in early trading; residual selling and guidance digestion typically continue into the next session. Risk is any positive commentary on demand or fuel hedging that sparks a rebound.
   Return: 0.09%; alpha: -0.31%.
2. VZ — confidence 68%. SpaceX definitive agreement to acquire nationwide 800 MHz low-band spectrum from Grain Management positions Starlink Mobile as a potential terrestrial competitor. Verizon shares dropped ~6-7% after-hours Thursday and continued lower Friday morning. Competitive overhang and further analyst notes are likely to sustain pressure over the one-session window. Risk is any clarifying statements limiting the near-term impact or tower-related offsets.
   Return: -0.21%; alpha: -0.01%.
3. TMUS — confidence 67%. Same SpaceX 800 MHz spectrum deal that triggered ~6-9% after-hours and early-session declines. T-Mobile is viewed as particularly exposed given prior spectrum transactions with Grain. Continuation of the competitive narrative into Monday is expected. Risk includes any positive industry commentary or FCC-related delays that could limit the selloff.
   Return: -0.39%; alpha: 0.17%.
4. JPM — confidence 65%. JPMorgan reports Q3 results before the open on Tuesday 2026-10-13. Consensus expects solid trading and investment-banking results amid strong capital-markets activity. Positioning and anticipation typically lift large banks in the session preceding the print, especially after a mixed macro week. Risk is any pre-announcement caution or rate-sensitivity concerns that dampen enthusiasm.
   Return: 1.21%; alpha: 0.99%.
5. GS — confidence 63%. Goldman Sachs reports Q3 before the open on Tuesday 2026-10-13 alongside other major banks. Strong trading and advisory revenue expectations support positive pre-earnings positioning. The one-session window captures anticipation rather than the post-print reaction. Risk is weaker-than-expected capital-markets commentary or broader financial-sector caution.
   Return: 1.72%; alpha: 1.50%.

Full prediction and audit record

Claude Sonnet 5.5

View full picks and reasoning

US indexes opened higher on Friday after a record-setting week, with oil easing on hopes of progress in US-Iran talks and AI-linked tech rebounding after Thursday's sell-off. Most of the big single-stock gaps were already in the price when this run was asked: the Humana Star Ratings jump, the telecom sell-off and tower rally after SpaceX's spectrum deal, Lumentum's optical sold-out comments, and Delta's guidance cut. Each pick below forecasts only the move from the quote I could find now to the same time on Monday, not the gap that already happened. The window ends before the Oct 13 bank and J&J earnings, so I did not use them. TMUS up and CCI down are two sides of one view: that the SpaceX-driven move overshot, so the two picks are correlated. Confidence is modest across the board because each name has already re-priced sharply, and weekend headline risk (US-Iran, oil, AI-demand data) cuts both ways.

1. HUM — confidence 52%. Observed fact: Humana reported improved 2027 Medicare Advantage Star Ratings after Thursday's close, with 95% of its Medicare Advantage members in plans rated 4 stars or above. Analysts called it the biggest beneficiary of the CMS release, and several raised targets or upgraded (Baird upgraded to Outperform with a $596 target; Barclays $582; Oppenheimer $475; Cantor upgraded earlier in the week). Thesis: a recovered Stars rating supports quality-bonus revenue and the 2028 margin target, so analyst revisions and a re-rating can keep running, and the Annual Election Period opening Oct 15 keeps attention on the name. Risks: the stock already gapped about 12-16%, opened near $450 and had faded to about $434 at my quote, so profit-taking is likely. The consensus target of about $445.61 is near the current price. Healthcare-policy headlines could also reverse the move. The price is an intraday quote from stockanalysis.com for 2026-10-09 around 10:12 AM EDT, possibly delayed up to 15 minutes. Market cap is as shown at that quote. avg_dollar_volume_20d_usd is my estimate: 20-day average share volume of 1,193,073 times the reference price, not a sum of daily dollar volumes. Both are reported as found and pass the floors.
   Return: -0.40%; alpha: -0.62%.
2. TMUS — confidence 50%. Observed facts: SpaceX agreed to acquire a nationwide low-band spectrum portfolio from Grain Management, which would let Starlink Mobile become a larger competitor to the big US carriers. T-Mobile fell about 9-10% to roughly $154, near its 52-week low of $153.71. AT&T and Verizon also fell sharply, and Scotiabank trimmed its target to $212 while keeping Outperform. Thesis: this is an overshoot. Analysts have long said a full nationwide SpaceX network would take years and heavy capital, the stock trades at about 13.6x forward earnings with a 3% dividend yield after a 15% dividend increase, RSI is about 34 and the shares are well below the 50-day average of about $175. A partial rebound over the next session is plausible, and the next earnings date (Oct 28) is outside the window. Risks: the competitive-threat narrative may keep spreading, more analyst target cuts could follow, and negative momentum often persists after gaps. Weekend headlines on SpaceX or the Grain deal could extend the drop. The price is an intraday quote from stockanalysis.com for 2026-10-09 around 10:09 AM EDT, possibly delayed up to 15 minutes. avg_dollar_volume_20d_usd is my estimate: 20-day average share volume of 5,044,328 times the reference price.
   Return: -0.39%; alpha: -0.61%.
3. LITE — confidence 45%. Observed fact: Lumentum's CEO told Bloomberg that its optoelectronics parts are completely sold out through nearly 2029, with supply shortfalls expected for some products through 2028. The shares gained about 4-8% on Friday and touched a new all-time high near $1,143. Optical peers (Ciena, Applied Optoelectronics, Coherent) rallied too, after AI-linked names fell on Thursday on a report that OpenAI's annualized revenue was about $20 billion lower than previously shared. Thesis: a multi-year supply-constrained backlog is a durable fundamental support, analyst targets are rising (Citi $1,400, Stifel $1,232, Bernstein $1,220; consensus about $1,162) and the shares have trended up strongly. Risks: the stock is up roughly 570% in 52 weeks and trades at about 50x forward earnings, so it is very exposed to any AI-capex wobble. The OpenAI revenue question could resurface over the weekend, and the CEO comments are already priced in after an intraday spike. The price is an intraday quote from stockanalysis.com for 2026-10-09 around 10:14-10:16 AM EDT, possibly delayed up to 15 minutes. avg_dollar_volume_20d_usd is my estimate: 20-day average share volume of 4,576,251 times the reference price.
   Return: -6.85%; alpha: -7.07%.
4. CCI — confidence 45%. Observed facts: Crown Castle closed at $68.89 on Oct 8, rose about 7% after hours and was up roughly 11-12% at the open on Oct 9 (about $76.25 at my quote, with a day range of $73.75-$79.42) after SpaceX agreed to buy a nationwide low-band spectrum portfolio. American Tower rose similarly. Thesis: this is a narrative-driven gap, not a change in Crown Castle's own fundamentals. JPMorgan downgraded the stock to Underweight with an $80 target about 25 days ago, the CFO is retiring, organic growth is guided to bottom in 2026, and the dividend was cut about 19% year over year with a payout ratio above 200% on earnings. The stock sat well inside its 52-week range of $65.32-$100.50 and the 50-day average was about $73.30, so most of the gap sits above the recent trading level. A partial fade over the next session is plausible, and the next earnings report (Oct 21) is outside the window. Risks: analysts may argue that an additional large terrestrial entrant needs towers, the gap could extend if SpaceX details emerge, and shorting a REIT after a news-driven jump can squeeze. The price is an intraday quote from stockanalysis.com for 2026-10-09 around 9:56 AM EDT, possibly delayed up to 15 minutes. avg_dollar_volume_20d_usd is my estimate: 20-day average share volume of 3,681,622 (from the Oct 8 statistics snapshot) times the reference price.
   Return: 3.75%; alpha: -3.97%.
5. DAL — confidence 40%. Observed facts: Delta reported Q3 results before the open on Oct 9. Adjusted EPS was $1.72 against consensus of about $1.75-$1.76, which CNBC described as its first miss in two years. It cut its 2026 EPS outlook to $5.10-$5.60 from $6.50-$7.50, cut its free-cash-flow outlook to $2.5 billion, and guided Q4 EPS to $1.15-$1.65 versus consensus of $1.42. The fuel bill rose roughly 62%. Management said demand remains strong. Thesis: guidance cuts after a first miss tend to produce analyst estimate cuts and modest negative drift, and shorts have been building (short interest about 4% of shares). The stock had already sold off to a low of $79.16 and rebounded to about $81, so I am fading the bounce. Risks: this is the lowest-conviction pick. Oil fell on US-Iran progress hopes, which helps airlines, Delta's revenue strength and premium demand are real, targets are around $100, and weekend oil or geopolitical news could easily send the stock higher. The price is an intraday quote from stockanalysis.com for 2026-10-09 around 10:10 AM EDT, possibly delayed up to 15 minutes. avg_dollar_volume_20d_usd is my estimate: 20-day average share volume of 8,005,547 times the reference price. Sources differ on the reported revenue figure, so I did not rely on it.
   Return: 0.09%; alpha: -0.31%.

Full prediction and audit record

DeepSeek

View full picks and reasoning

US equities enter the window with sharp idiosyncratic dispersion. The SpaceX spectrum deal has triggered a structural selloff in telecom carriers, while CMS Medicare Advantage star-rating changes are creating extreme movers in managed care. Apple faces demand-side pressure from component order cuts. The window spans a weekend and ends Monday morning, so Friday afternoon positioning, weekend news flow, and Monday pre-market activity will dominate. Momentum in the most affected names may persist as analysts revise estimates.

1. HUM — confidence 75%. Humana surged ~14-17% in after-hours and pre-market trading after CMS awarded its largest Medicare Advantage contract (H5216, covering 2M+ members) a 4-star rating for 2027, up from 3.5 stars, restoring bonus eligibility. The catalyst occurred on Oct 8 after close, but the move is still being digested. Analyst upgrades (Baird to Outperform, $596 PT; Oppenheimer to $475 PT) followed on Oct 9 and could fuel further gains through Monday. The main risk is profit-taking after the sharp initial pop, but positive estimate revisions and the structural improvement in bonus revenue support continued upside from Friday mid-morning to Monday mid-morning.
   Return: -0.40%; alpha: -0.62%.
2. TEVA — confidence 70%. Teva Pharmaceutical Industries received FDA approval for Weltruza (olanzapine LAI), a once-monthly injectable for schizophrenia, on October 9, 2026. The stock jumped ~6.6% intraday on the news. The approval is a material positive catalyst that expands Teva's long-acting injectable portfolio and is expected to launch in the US in the coming weeks. The initial move has occurred, but continued analyst recognition and commercial launch anticipation could support further gains through Monday. Risks include profit-taking and the stock already trading near 52-week highs.
   Return: -1.22%; alpha: -1.44%.
3. T — confidence 72%. AT&T dropped ~9% at the open on October 9 after SpaceX announced a definitive agreement on October 8 to acquire a nationwide 800MHz low-band spectrum portfolio from Grain Management, positioning Starlink to enter the US mobile market. The competitive threat is structural and ongoing. Analysts downgraded price targets (Scotiabank cut T to $26.50 from $27.50). The initial selloff has occurred, but the market is likely to continue repricing telecom carriers as the implications for churn, pricing, and capital spending become clearer. The window from Friday mid-morning to Monday mid-morning may see continued downside as the market digests the competitive threat.
   Return: -0.96%; alpha: 0.74%.
4. VZ — confidence 68%. Verizon fell ~6-7% on October 9 following the SpaceX spectrum deal, which signals a credible new entrant into the US wireless market. Verizon has invested heavily in terrestrial spectrum and network infrastructure, and the threat of Starlink mobile services could pressure pricing and subscriber growth. Scotiabank lowered its price target to $50 from $51.50. The initial drop has occurred, but the structural nature of the competitive threat suggests continued downside as the market assesses long-term implications. The window captures Friday afternoon through Monday morning, a period likely to see further analyst revisions and negative sentiment.
   Return: -0.21%; alpha: -0.01%.
5. AAPL — confidence 65%. Apple fell ~1.7-2% in pre-market trading on October 9 after Nikkei Asia reported that the company asked suppliers to cut component orders for the iPhone 18 Pro and iPhone 18 Pro Max by 15-20% for October due to soft demand and rising memory chip costs. The report is a negative demand signal for Apple's premium handset lineup. While the initial drop has occurred, the demand concerns are likely to persist and could weigh on the stock through Monday as analysts assess the implications for Q4 iPhone revenue. Risks include a broader market rebound or Apple-specific buying support, but the near-term catalyst is negative.
   Return: 2.84%; alpha: -3.06%.

Full prediction and audit record

How models have done in Event Gaps

ForecastNest's own settled Event Gaps runs at this horizon, up to and including this one. Members' own research is not counted. Event Gaps forecasts must have been created during regular US market hours to enter these statistics. Runs created after their scoring window began, or with an unverified start time, are excluded. The chart is the average alpha vs SPY per run. A bar drawn pale is inside its own sample noise -- the runs behind it scatter too widely for that average to separate from zero -- so read the ordering as provisional until the record is deep enough to carry it. The table below adds how many of the five picks beat SPY, which is a steadier measure on a short record because it counts several picks a run rather than one result.

Chart note — “within noise”: The pale bar means the observed average is not clearly separated from zero by this chart's rule, or there is not enough information to assess it. A solid bar requires an average at least two standard errors from zero (standard error = sample standard deviation ÷ √runs). Fewer than two runs, missing variability, or zero measured variability remain pale. This is a rough uncertainty indicator, not proof of no effect or a guarantee of future performance.

Model	Runs	Avg picks with positive alpha	Avg alpha vs SPY
Claude Opus 5.5	3	53.33%	+0.85%
Grok 4.5	10	48.00%	+0.67%
DeepSeek	12	55.42%	+0.63%
ChatGPT	1	60.00%	+0.50%
Gemini 1.5 Pro	11	50.91%	+0.28%
GPT-6	4	40.00%	-0.07%
Grok 4	1	40.00%	-0.09%
Perplexity	10	36.00%	-0.25%
Claude Opus 5	1	40.00%	-0.25%
Gemini 3 Pro	1	40.00%	-0.27%
Muse Spark 1.1	12	45.00%	-0.48%
Claude Sonnet 5.5	8	32.50%	-1.33%
GPT-5.6 Sol	7	40.00%	-1.42%
Kimi	1	20.00%	-5.18%

View settlement prices

Symbol	Start	End	Source	Notes
AAPL	332.56000000	342.01000000	https://finance.yahoo.com/quote/AAPL/history/
AMD	615.21890000	591.69000000	https://finance.yahoo.com/quote/AMD/history/
CCI	76.25500000	79.11500000	https://finance.yahoo.com/quote/CCI/history/
CEG	292.71110000	296.99000000	https://finance.yahoo.com/quote/CEG/history/
DAL	80.96500000	81.03500000	https://finance.yahoo.com/quote/DAL/history/
GS	879.23000000	894.35000000	https://finance.yahoo.com/quote/GS/history/
HUM	433.77000000	432.03000000	https://finance.yahoo.com/quote/HUM/history/
JPM	330.72500000	334.74000000	https://finance.yahoo.com/quote/JPM/history/
LEVI	18.51500000	18.95500000	https://finance.yahoo.com/quote/LEVI/history/
LITE	1096.63000000	1021.50000000	https://finance.yahoo.com/quote/LITE/history/
SPY	776.02000000	777.74000000	https://finance.yahoo.com/quote/SPY/history/
T	22.80500000	22.58500000	https://finance.yahoo.com/quote/T/history/
TEVA	41.55500000	41.05010000	https://finance.yahoo.com/quote/TEVA/history/
TMUS	153.74670000	153.14690000	https://finance.yahoo.com/quote/TMUS/history/
VZ	42.79000000	42.70000000	https://finance.yahoo.com/quote/VZ/history/

Standard prompt event-gap-v12, SHA-256 aa11b53950c2dcdc1d0b3a46807defe6fdee4d8dc19ea905a8cb1cad36360b07. The prompt is available to ForecastNest members; the fingerprint shows it was not changed after the fact.

Calculation: event-gap-v3-window-direction.